116 related articles for article (PubMed ID: 11511919)
21. Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An unusually high prevalence of ras mutations.
Zhu Z; Gandhi M; Nikiforova MN; Fischer AH; Nikiforov YE
Am J Clin Pathol; 2003 Jul; 120(1):71-7. PubMed ID: 12866375
[TBL] [Abstract][Full Text] [Related]
22. Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk.
Mössner R; Meyer P; Jankowski F; König IR; Krüger U; Kammerer S; Westphal G; Boettger MB; Berking C; Schmitt C; Brockmöller J; Ziegler A; Stapelmann H; Kaiser R; Volkenandt M; Reich K
Cancer Lett; 2007 Feb; 246(1-2):218-23. PubMed ID: 16713673
[TBL] [Abstract][Full Text] [Related]
23. Inconsistent effects of the proline12 --> alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls.
Witchel SF; White C; Siegel ME; Aston CE
Fertil Steril; 2001 Oct; 76(4):741-7. PubMed ID: 11591408
[TBL] [Abstract][Full Text] [Related]
24. Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.
Gimm O; Dziema H; Brown J; Hoang-Vu C; Hinze R; Dralle H; Mulligan LM; Eng C
Oncogene; 2001 Apr; 20(17):2161-70. PubMed ID: 11360200
[TBL] [Abstract][Full Text] [Related]
25. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas.
Aldred MA; Morrison C; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang S; Eng C
Oncogene; 2003 May; 22(22):3412-6. PubMed ID: 12776192
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis.
Masugi J; Tamori Y; Mori H; Koike T; Kasuga M
Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233
[TBL] [Abstract][Full Text] [Related]
27. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells.
Ohta K; Endo T; Haraguchi K; Hershman JM; Onaya T
J Clin Endocrinol Metab; 2001 May; 86(5):2170-7. PubMed ID: 11344222
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma upregulates caveolin-1 and caveolin-2 expression in human carcinoma cells.
Burgermeister E; Tencer L; Liscovitch M
Oncogene; 2003 Jun; 22(25):3888-900. PubMed ID: 12813462
[TBL] [Abstract][Full Text] [Related]
29. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
[TBL] [Abstract][Full Text] [Related]
30. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
[TBL] [Abstract][Full Text] [Related]
31. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
Valve R; Sivenius K; Miettinen R; Pihlajamäki J; Rissanen A; Deeb SS; Auwerx J; Uusitupa M; Laakso M
J Clin Endocrinol Metab; 1999 Oct; 84(10):3708-12. PubMed ID: 10523018
[TBL] [Abstract][Full Text] [Related]
32. Single nucleotide polymorphism of pi-class glutathione s-transferase and susceptibility to endometrial carcinoma.
Chan QK; Khoo US; Ngan HY; Yang CQ; Xue WC; Chan KY; Chiu PM; Ip PP; Cheung AN
Clin Cancer Res; 2005 Apr; 11(8):2981-5. PubMed ID: 15837751
[TBL] [Abstract][Full Text] [Related]
33. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
[TBL] [Abstract][Full Text] [Related]
34. Multiple variants of the peroxisome proliferator-activated receptor (PPAR) gamma are expressed in the liver of atlantic salmon (Salmo salar).
Andersen O; Eijsink VG; Thomassen M
Gene; 2000 Sep; 255(2):411-8. PubMed ID: 11024302
[TBL] [Abstract][Full Text] [Related]
35. Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
Zhang Y; Yu J; Lee C; Xu B; Sartor MA; Koenig RJ
Oncotarget; 2015 Dec; 6(38):40418-32. PubMed ID: 26595524
[TBL] [Abstract][Full Text] [Related]
36. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors.
Souza RF; Yin J; Smolinski KN; Zou TT; Wang S; Shi YQ; Rhyu MG; Cottrell J; Abraham JM; Biden K; Simms L; Leggett B; Bova GS; Frank T; Powell SM; Sugimura H; Young J; Harpaz N; Shimizu K; Matsubara N; Meltzer SJ
Cancer Res; 1997 Jun; 57(12):2350-3. PubMed ID: 9192806
[TBL] [Abstract][Full Text] [Related]
37. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance.
Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY
J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069
[TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
39. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
